Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.51 HKD | -1.92% | +2.00% | -22.73% |
Apr. 22 | Lexeo Therapeutics Signs License Deal With Cornell for Potential Friedreich Ataxia Cardiomyopathy Drug | MT |
Apr. 17 | Future Data Group Limited Announces Changes to its Board | CI |
Sales 2022 | 618M 79.16M | Sales 2023 | 482M 61.78M | Capitalization | 361M 46.25M |
---|---|---|---|---|---|
Net income 2022 | -3M -385K | Net income 2023 | -16M -2.05M | EV / Sales 2022 | 0.16 x |
Net cash position 2022 | 56.95M 7.3M | Net cash position 2023 | 122M 15.68M | EV / Sales 2023 | 0.49 x |
P/E ratio 2022 |
-50.3
x | P/E ratio 2023 |
-19.9
x | Employees | 243 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.25% |
1 day | -1.92% | ||
1 week | +2.00% | ||
3 months | -12.07% | ||
6 months | -34.62% | ||
Current year | -22.73% |
Managers | Title | Age | Since |
---|---|---|---|
Seung-Han Lee
FOU | Founder | 53 | 16-06-30 |
Ting Pong Cheung
CEO | Chief Executive Officer | 44 | 23-05-15 |
Yuk Kan Lo
CTO | Chief Tech/Sci/R&D Officer | - | 23-08-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Xia Tao
CHM | Chairman | 50 | 22-10-30 |
Ting Pong Cheung
CEO | Chief Executive Officer | 44 | 23-05-15 |
Seung-Han Lee
FOU | Founder | 53 | 16-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-17 | 0.51 | -1.92% | 695,000 |
24-05-16 | 0.52 | 0.00% | 705,000 |
24-05-14 | 0.52 | +1.96% | 825,000 |
24-05-13 | 0.51 | +2.00% | 725,000 |
24-05-10 | 0.5 | -1.96% | 625,000 |
Delayed Quote Hong Kong S.E., May 17, 2024 at 04:08 am EDT
More quotesAnnual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.73% | 35.74M | |
+5.34% | 35.9B | |
+4.27% | 15.76B | |
-6.76% | 9.06B | |
+0.05% | 7.09B | |
+14.48% | 5.54B | |
-46.16% | 4.48B | |
+7.76% | 2.9B | |
-15.24% | 2.32B | |
+0.38% | 2.29B |
- Stock Market
- Equities
- 8229 Stock